10月19日，Moderna盘前下跌3.22%，报211.03美元/股，成交额1214.83万美元。
消息面上，公司高管Stephen Hoge于10月14日和10月15日合计减持78369股，且此前股价在癌症疫苗利好交易后已出现明显回吐，市场短线情绪转弱。
与此同时，最新期权大单显示资金以熊市看涨价差和高位收租为主，隐含波动率处于99%分位，反映机构更倾向判断反弹空间受限，叠加前一交易日股价大跌7.82%，共同压制盘前表现。
Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸医学领域的领导者，业务覆盖传染病、免疫肿瘤学、罕见病和自身免疫性疾病。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.